From: Diabetes and hypertension MobileHealth systems: a review of general challenges and advancements
Author/year | Purpose or class | ML algorithm | Data Desc. | ACC | SEN | SP | PR | ROC-AUC | F | NPV | Dataset | HMS Inc. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
[82]/2019 | Hyp. Pred. (PH) | RFr, RFc, LLR, Boosted C5.0, SVM | Echo | RFc (85) | SVM (95) | RFr/RFc (67) | RFc (90) | RFr (87) | SVM (76) | - | HMIS | No |
[89]/2020 | Hyp. Pred. (PH) | LB, LDA, SVM, KNN, DT, AB, GD, LR | 13 Echo+RHC | LB (87) | LB (90) | - | LB (87) | LB (87) | LB (83) | LB (88) | - | No |
[86]/2021 | Hyp. Pred. (PAH) | XGB, Rpart, RF, Ensemble | - | XGB (83) | Rpart/XGB/Ensemble (91) | RF/XGB (71) | RF/XGB (83) | RF (84) | - | XGB (83) | - | No |
[83]/2021 | Hyp. Pred. (based on | RF, CatBoost, MLP, LR | 29,700 samples | RF (82) | RF (83) | RF (81) | - | RF (92) | - | - | UCI | No |
easy-to-collect factors) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
[51]/2022 | NT/PHT | SVM, LR, LDA, KNN, DT | PPG+WST | SVM (71.42) | SVM (52.38/90.47) | - | SVM (84.61/65.51) | - | SVM (64.70/76.60) | - | PPG-BP | No |
NT/PHT | SVM, LR, LDA, KNN, DT | C+S | SVM (64.29) | SVM (52.38/76.19) | - | SVM (68.75/61.54) | - | SVM (59.46/68.09) | - | PPG-BP | No | |
[76]/2018 | Hyp. Pred. | SVM, MLP, LR, NB, C4.5, RF, HPM | 175 samples | HPM (76.42) | HPM (70.27) | SVM/C4.5 (96.04) | HPM (78.79) | - | HPM (82.2) | - | Golino et al. [90] | No |
[88]/2018 | Hyp. Pred | LB, BN, LWNB, SVM, RF, ANN | 23,095 samples | - | RF (69.96) | RF (91.71) | RF (81.69) | RF (93) | RF (86.70) | - | Â | No |
[84]/2021 | Risk factors | ANN, DT, RF, GB, SVM, LASSO, SVMRFE | 6956 samples | SVMRFE-GB (66.98) | SVMRFE-GB (97.92) | - | - | - | SVMRFE-GB (78.99) | - | Survey | No |
[85]/2020 | Risk factors | DT, LR, RF | 987 records | DT/RF (82.1) | DT/RF (82.1) | - | RF (81.4) | - | RF (81.6) | - | QBB | No |
[87]/2022 | Risk factors | RF, DT, XGB, GB, LR, LDA | 818603 samples | XGB/GB/LR/LDA (90) | =ACC | - | DT (91) | - | =ACC | - | Survey | No |